Literature DB >> 9186440

Blebitis, early endophthalmitis, and late endophthalmitis after glaucoma-filtering surgery.

T A Ciulla1, A D Beck, T M Topping, A S Baker.   

Abstract

PURPOSE: The differentiating characteristics in blebitis and early and late endophthalmitis after glaucoma filtration surgery are reviewed.
METHODS: All admission records and operative reports, as well as available office notes, on patients with blebitis or bleb-associated endophthalmitis admitted to a large referral eye center from 1985 to 1995 were reviewed retrospectively.
RESULTS: Ten cases of blebitis and 33 cases of bleb-associated endophthalmitis were identified. One patient with blebitis progressed to culture-positive endophthalmitis. Of the 33 cases of bleb-associated endophthalmitis, there were 6 cases of early endophthalmitis (before postoperative week 6) and 27 cases of late endophthalmitis. In early endophthalmitis, Staphylococcus epidermidis was isolated on vitreous culture in 4 (67%) of 6 cases, whereas in late endophthalmitis, this organism was isolated in only 1 (4%) of 27 cases. In the 27 late cases, Streptococcus species and gram-negative organisms comprised 48% of isolates; of 33 cases of endophthalmitis, 15 (45%) demonstrated no growth on vitreous culture. Patients with endophthalmitis fared more poorly than those with blebitis in terms of visual outcome.
CONCLUSIONS: Because blebitis may be prodromal to endophthalmitis, aggressive antimicrobial therapy, perhaps with oral quinolones, is warranted. In addition, patients with blebitis should be observed closely to identify extension into the vitreous cavity so that intravitreous antibiotics can be administered in a timely fashion. Finally, clinicians should not extrapolate the results of the Endophthalmitis Vitrectomy Study to the postfiltration surgery endophthalmitis given the differing pathogenesis and unique spectrum of organisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186440     DOI: 10.1016/s0161-6420(97)30196-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  19 in total

1.  Should we vaccinate for glaucoma surgery?

Authors:  R R Seemongal-Dass; T E James
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Risk factors for development of post-trabeculectomy endophthalmitis.

Authors:  O J Lehmann; C Bunce; M M Matheson; V Maurino; P T Khaw; R Wormald; K Barton
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

3.  Posttrabeculectomy endophthalmitis caused by Moraxella nonliquefaciens.

Authors:  Helene Laukeland; Kåre Bergh; Lars Bevanger
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

4.  A review of trabeculectomies at a nigerian teaching hospital.

Authors:  Bo Adegbehingbe; T Majemgbasan
Journal:  Ghana Med J       Date:  2007-12

5.  [Deep sclerectomy. An alternative to trabeculectomy].

Authors:  M Klemm
Journal:  Ophthalmologe       Date:  2015-04       Impact factor: 1.059

6.  Haemophilus influenzae associated scleritis.

Authors:  S O Sykes; C Riemann; C I Santos; D M Meisler; C Y Lowder; J P Whitcher; E T Cunningham
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

7.  Bleb-related Endophthalmitis: Clinical Presentation, Isolates, Treatment and Visual Outcome of Culture-proven Cases.

Authors:  Basel T Ba'arah; William E Smiddy
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01

8.  Changes in filtering bleb morphology after bleb-related infection.

Authors:  Akira Sawada; Yasuaki Kuwayama; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2015-07-30       Impact factor: 2.447

9.  Blindness following bleb-related infection in open angle glaucoma.

Authors:  Hiroki Yamada; Akira Sawada; Yasuaki Kuwayama; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2014-09-25       Impact factor: 2.447

10.  FRIENDS Group: clinical and microbiological characteristics of post-filtering surgery endophthalmitis.

Authors:  E Brillat-Zaratzian; A Bron; F Aptel; J P Romanet; P L Cornut; F Vandenesch; S Boisset; M Maurin; C Chiquet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-19       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.